119 related articles for article (PubMed ID: 30775274)
21. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
[TBL] [Abstract][Full Text] [Related]
22. Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on?
Kim HW; Min J; Ko Y; Oh JY; Jeong YJ; Lee EH; Yang B; Koo HK; Lee SS; Park JS; Park KJ; Chang JH; Joh J; Lee MK; Kim JS
Front Public Health; 2023; 11():1247772. PubMed ID: 37927864
[TBL] [Abstract][Full Text] [Related]
23. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
[TBL] [Abstract][Full Text] [Related]
24. The effect of TB patient delay on loss to follow-up in Portugal.
Marques J; Rocha JV; Soares P; Leite A; Duarte R; Nunes C
Int J Tuberc Lung Dis; 2023 Jul; 27(7):537-542. PubMed ID: 37353867
[No Abstract] [Full Text] [Related]
25. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors Associated with Loss to Follow-Up during Tuberculosis Treatment in the Sanatorium Hospital of Luanda, Angola.
Vita D; Aznar ML; Martínez-Campreciós J; Kansietoko DCMS; Molina I
Trop Med Infect Dis; 2024 Jun; 9(6):. PubMed ID: 38922043
[TBL] [Abstract][Full Text] [Related]
27. Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study.
Kim HW; Min J; Shin AY; Koo HK; Lim SY; Park MJ; Park YB; Lee J; Lee SS; Park JS; Kim JS
Int J Tuberc Lung Dis; 2020 Oct; 24(10):1016-1023. PubMed ID: 33126933
[No Abstract] [Full Text] [Related]
28. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
29. Pre-treatment loss to follow-up among smear-positive TB patients in tertiary hospitals, Quetta, Pakistan.
Wali A; Kumar AMV; Hinderaker SG; Heldal E; Qadeer E; Fatima R; Ullah A; Safdar N; Yaqoob A; Anwar K; Ul Haq M
Public Health Action; 2017 Mar; 7(1):21-25. PubMed ID: 28775939
[No Abstract] [Full Text] [Related]
30. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
[TBL] [Abstract][Full Text] [Related]
31. Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network.
Agwu AL; Lee L; Fleishman JA; Voss C; Yehia BR; Althoff KN; Rutstein R; Mathews WC; Nijhawan A; Moore RD; Gaur AH; Gebo KA
J Adolesc Health; 2015 Mar; 56(3):345-51. PubMed ID: 25703322
[TBL] [Abstract][Full Text] [Related]
32. A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.
Tok PSK; Wong LP; Liew SM; Razali A; Mahmood MI; Chinnayah T; Kawatsu L; Toha HR; Mohd Yusof K; Abd Rahman R; Che Mat Din SNA; Loganathan T
PLoS One; 2023; 18(9):e0289222. PubMed ID: 37676902
[TBL] [Abstract][Full Text] [Related]
33. Where, when, and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe.
Murongazvombo AS; Dlodlo RA; Shewade HD; Robertson V; Hirao S; Pikira E; Zhanero C; Taruvinga RK; Andifasi P; Tshuma C
Int J Infect Dis; 2019 Jan; 78():113-120. PubMed ID: 30368019
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with loss to follow-up among TB patients in rural Papua New Guinea.
Umo I; Kulai M; Commons RJ
Public Health Action; 2021 Dec; 11(4):186-190. PubMed ID: 34956846
[TBL] [Abstract][Full Text] [Related]
35. Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.
Obeid A; Gao X; Ali FS; Talcott KE; Aderman CM; Hyman L; Ho AC; Hsu J
Ophthalmology; 2018 Sep; 125(9):1386-1392. PubMed ID: 29606377
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
37. Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa.
Rachlis B; Bakoyannis G; Easterbrook P; Genberg B; Braithwaite RS; Cohen CR; Bukusi EA; Kambugu A; Bwana MB; Somi GR; Geng EH; Musick B; Yiannoutsos CT; Wools-Kaloustian K; Braitstein P
PLoS One; 2016; 11(8):e0159994. PubMed ID: 27509182
[TBL] [Abstract][Full Text] [Related]
38. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
[TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
